TrialThe European journal of health economics : HEPAC : health economics in prevention and care2025
Cancer-specific utility: clinical validation of the EORTC QLU-C10D in patients with glioblastoma.
Simone Seyringer et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it